The US Centers for Disease Control and Prevention (CDC) today in its weekly measles update reported 29 more cases, bringing ...

In other developments, the ECDC today reported a slow rise in COVID activity in the Europe, which may partly reflect waning ...

The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease.

Dengue survivors are at increased risk for post-infection multi-organ complications, all-cause hospitalization, and death, ...